Question 1

What are the potential benefits of switching to Mircera from epoetin alfa?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia clinical trial (NCT00048035). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my response to Mircera be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia clinical trial (NCT00048035). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with Mircera?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia clinical trial (NCT00048035). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia clinical trial (NCT00048035). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia clinical trial (NCT00048035). Contact the study team or your healthcare provider for specific answers.

Question 6

How does this trial compare to other anemia treatments available?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia clinical trial (NCT00048035). Contact the study team or your healthcare provider for specific answers.

What this study is about